| Product NDC: | 63323-311 |
| Proprietary Name: | Calcium Gluconate |
| Non Proprietary Name: | CALCIUM GLUCONATE |
| Active Ingredient(s): | 94 mg/mL & nbsp; CALCIUM GLUCONATE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-311 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20000712 |
| Package NDC: | 63323-311-10 |
| Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-311-10) > 10 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 63323-311-10 |
| Proprietary Name | Calcium Gluconate |
| Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-311-10) > 10 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 63323-311 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CALCIUM GLUCONATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20000712 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | CALCIUM GLUCONATE |
| Strength Number | 94 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient] |